Psoriasis: a brief overview.
Raharja A, Mahil SK, Barker JN.
Clin Med (Lond). 2021 May;21(3):170-173. doi: 10.7861/clinmed.2021-0257.
Biological treatment for erythrodermic psoriasis.
Dogra S, Mehta H.
Expert Opin Biol Ther. 2022 Dec;22(12):1531-1543. doi: 10.1080/14712598.2022.2128669. Epub 2022 Sep 28.
[Erythrodermic psoriasis].
Rollin L, Rioual N, Aubret J, Dolghin M, Fouilland X.
Rev Prat. 2024 Jan;74(1):56-57.
Erythrodermic psoriasis improved by Tildrakizumab.
Trevisan G, Germi L, Naldi L.
Dermatol Reports. 2022 Nov 23;14(4):9448. doi: 10.4081/dr.2022.9448. eCollection 2022 Nov 21.
Treatment of erythrodermic psoriasis with biologics: A systematic review.
Carrasquillo OY, Pabón-Cartagena G, Falto-Aizpurua LA, Santiago-Vázquez M, Cancel-Artau KJ, Arias-Berrios G, Martín-García RF.
J Am Acad Dermatol. 2020 Jul;83(1):151-158. doi: 10.1016/j.jaad.2020.03.073. Epub 2020 Apr 2.
Erythrodermic psoriasis.
Mumoli N, Vitale J, Gambaccini L, Sabatini S, Brondi B, Cei M.
QJM. 2014 Apr;107(4):315. doi: 10.1093/qjmed/hct139. Epub 2013 Jun 12.
Management of Erythrodermic Psoriasis with Systemic Therapies: A Systematic Review.
Mastorino L, Leo F, Frigatti G, Macagno N, Dapavo P, Quaglino P, Ribero S.
Am J Clin Dermatol. 2025 Nov;26(6):877-893. doi: 10.1007/s40257-025-00977-1. Epub 2025 Aug 26.
Psoriasis management tree based on comorbidity.
Amara S, Pasumarthi A, Parikh N, Kodali N, Lebwohl M, Monks G.
Int J Dermatol. 2025 Feb;64(2):229-245. doi: 10.1111/ijd.17497. Epub 2024 Oct 17.
Erythrodermic psoriasis.
Brenner S, Wolf R.
J Am Acad Dermatol. 1991 Feb;24(2 Pt 1):324. doi: 10.1016/s0190-9622(08)80643-3.
Psoriasis: Recognition and Management Strategies.
Garner KK, Hoy KDS, Carpenter AM.
Am Fam Physician. 2023 Dec;108(6):562-573.
